HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of a cash transfer programme on tuberculosis treatment success rate: a quasi-experimental study in Brazil.

AbstractBACKGROUND:
Evidence suggests that social protection policies such as Brazil's Bolsa Família Programme (BFP), a governmental conditional cash transfer, may play a role in tuberculosis (TB) elimination. However, study limitations hamper conclusions. This paper uses a quasi-experimental approach to more rigorously evaluate the effect of BFP on TB treatment success rate.
METHODS:
Propensity scores were estimated from a complete-case logistic regression using covariates from a linked data set, including the Brazil's TB notification system (SINAN), linked to the national registry of those in poverty (CadUnico) and the BFP payroll.
RESULTS:
The average effect of treatment on the treated was estimated as the difference in TB treatment success rate between matched groups (ie, the control and exposed patients, n=2167). Patients with TB receiving BFP showed a treatment success rate of 10.58 percentage points higher (95% CI 4.39 to 16.77) than patients with TB not receiving BFP. This association was robust to sensitivity analyses.
CONCLUSIONS:
This study further confirms a positive relationship between the provision of conditional cash transfers and TB treatment success rate. Further research is needed to understand how to enhance access to social protection so to optimise public health impact.
AuthorsDaniel J Carter, Rhian Daniel, Ana W Torrens, Mauro N Sanchez, Ethel Leonor N Maciel, Patricia Bartholomay, Draurio C Barreira, Davide Rasella, Mauricio L Barreto, Laura C Rodrigues, Delia Boccia
JournalBMJ global health (BMJ Glob Health) Vol. 4 Issue 1 Pg. e001029 ( 2019) ISSN: 2059-7908 [Print] England
PMID30740248 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: